“Fenoldopam as a Possible Medication for Non-Occlusive Mesenteric Ischemia (NOMI) and Contrast-Induced Nephropathy?”, Bangladesh J Infect Dis, vol. 8, no. 1, pp. 53–54, Jan. 2022, doi: 10.3329/bjid.v8i1.53742.